home.aspx

 
.

DRUG DEVELOPMENT – THE 6 MOST CRITICAL REASONS WHY DRUGS ARE DELAYED WHEN PLANNING AND CONDUCTING CTA/IND ENABLING STUDIES

SHARESHARESHARE
Bringing a drug from discovery to market is an expensive and time-consuming business. Every drug that fails comes with a cost which could be both reputational and financial. Keeping your development program on track is therefore critical to success. In this webinar, our featured speaker will explore the 6 most critical reasons why drugs are delayed when planning and conducting a Clinical Trial Application (CTA)/Investigational New Drug Application (IND) enabling studies. Having gathered input from a wide-ranging group of senior drug development scientists, this webinar will use clinical examples to explore what drug developers misjudge or simply overlook when seeking to bring small or large molecules out from the lab and into the clinic.